Northern Trust’s MyoKardia, Inc. Common Stock MYOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-638,688
| Closed | -$87.1M | – | 4452 |
|
|
2020
Q3 | $87.1M | Sell |
638,688
-28,698
| -4% | -$3.05M | 0.02% | 623 |
|
|
2020
Q2 | $64.5M | Buy |
667,386
+79,842
| +14% | +$6.66M | 0.02% | 722 |
|
|
2020
Q1 | $27.5M | Buy |
587,544
+7,631
| +1% | +$489K | 0.01% | 1181 |
|
|
2019
Q4 | $42.3M | Sell |
579,913
-14,827
| -2% | -$899K | 0.01% | 1141 |
|
|
2019
Q3 | $31M | Buy |
594,740
+128,074
| +27% | +$6.81M | 0.01% | 1334 |
|
|
2019
Q2 | $23.4M | Buy |
466,666
+47,944
| +11% | +$2.33M | 0.01% | 1565 |
|
|
2019
Q1 | $21.8M | Buy |
418,722
+4,723
| +1% | +$218K | 0.01% | 1615 |
|
|
2018
Q4 | $20.2M | Sell |
413,999
-3,782
| -0.9% | -$208K | 0.01% | 1575 |
|
|
2018
Q3 | $27.2M | Buy |
417,781
+41,242
| +11% | +$2.43M | 0.01% | 1530 |
|
|
2018
Q2 | $18.7M | Buy |
376,539
+135,364
| +56% | +$6.55M | ﹤0.01% | 1832 |
|
|
2018
Q1 | $11.8M | Buy |
241,175
+2,037
| +0.9% | +$106K | ﹤0.01% | 2066 |
|
|
2017
Q4 | $10.1M | Buy |
239,138
+13,671
| +6% | +$527K | ﹤0.01% | 2181 |
|
|
2017
Q3 | $9.66M | Buy |
225,467
+22,484
| +11% | +$717K | ﹤0.01% | 2230 |
|
|
2017
Q2 | $2.66M | Buy |
202,983
+49,044
| +32% | +$646K | ﹤0.01% | 2993 |
|
|
2017
Q1 | $2.02M | Sell |
153,939
-15,376
| -9% | -$197K | ﹤0.01% | 3078 |
|
|
2016
Q4 | $2.19M | Buy |
169,315
+35,198
| +26% | +$542K | ﹤0.01% | 3033 |
|
|
2016
Q3 | $2.19M | Buy |
134,117
+23,431
| +21% | +$423K | ﹤0.01% | 3023 |
|
|
2016
Q2 | $1.37M | Buy |
110,686
+48,903
| +79% | +$611K | ﹤0.01% | 3232 |
|
|
2016
Q1 | $661K | Sell |
61,783
-1,103
| -2% | -$10K | ﹤0.01% | 3388 |
|
|
2015
Q4 | $922K | Buy |
+62,886
| New | +$769K | ﹤0.01% | 3348 |
|
Northern Trust's MYOK Position: Q4 2020 in Review
Northern Trust sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 638,688 shares — an estimated $87.1M sold.
Northern Trust first reported a position in MYOK in Q4 2015 and held it in 20 quarters. The position peaked at $87.1M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.
- Northern Trust reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
- Northern Trust sold 638,688 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $87.1M.
- Northern Trust first reported a position in MyoKardia, Inc. Common Stock in Q4 2015 and held it in 20 quarters.
- Northern Trust's MyoKardia, Inc. Common Stock position peaked at $87.1M in Q3 2020.
- 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.
Based on Northern Trust's 13F filing for Q4 2020, filed 11 Feb 2021.